Search Results - dawn+cochrane

2 Results Sort By:
Anti-androgen therapy in triple-negative breast cancer
Methods of treating breast cancer with anti-androgen compounds. Reference patent 9,517,229 and application 15/373,914.
Published: 12/1/2023   |   Inventor(s): Jennifer Richer Mouchantat, Dawn Cochrane, Andy Protter
Disease Areas Oncology
Category(s): Therapeutics
Micro RNAs that target metabolic enzymes and nutrient transporters in breast cancer
Patients with triple-negative breast cancer often have increased risk for recurrence and metastasis as well as decreased 5-year survival. Since triple-negative breast cancers don’t depend on hormone receptors or HER for growth, triple-negative cancers do not respond to hormone or HER dependent therapies. Jennifer Richer and her research team have...
Published: 11/30/2023   |   Inventor(s): Jennifer Richer Mouchantat, Dawn Cochrane, Steven Anderson
Disease Areas Endocrine/Metabolism, Oncology
Category(s): Diagnostics
For inquiries, email: cuinnovations@cuanschutz.edu.     © 2024. All Rights Reserved. Powered by Inteum